The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Acura Pharmaceuticals
ACUR
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.020000
0
0.00%
At close: Jul 12, 2:05 PM EDT
15 minutes delayed
Get Report
Comment
Acura Pharmaceuticals (ACUR) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Acura Pharmaceuticals (OTC:ACUR) Stock
Acura Pharmaceuticals Stock (OTC: ACUR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 14, 2021
Acura Pharmaceuticals Granted U.S. Patent #11,197,837 'Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse'
Charles Gross
Monday, February 10, 2020
Acura Pharmaceuticals Q2 EPS $(0.15) Down Fro...
Benzinga Newsdesk
Tuesday, November 05, 2019
Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin
Friday, September 06, 2019
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Wednesday, July 03, 2019
The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief
Shanthi Rexaline
Wednesday, January 03, 2018
Form 4 Filing Out Late Tuesday Shows Acura Ph...
Benzinga
Monday, August 14, 2017
Acura Pharmaceuticals Reports Q2 EPS $(0.18) ...
Benzinga
Thursday, May 18, 2017
Acura Pharma Reports Initiation of Second Cli...
Benzinga
Thursday, February 16, 2017
22 Biggest Mid-Day Losers For Thursday
Benzinga
Wednesday, February 08, 2017
20 Biggest Mid-Day Losers For Wednesday
Benzinga
Tuesday, February 07, 2017
Acura Pharmaceuticals Shares Up ~160 At $1.29...
Benzinga
Friday, February 03, 2017
S-1 from Acura Pharma Shows Registration for ...
Benzinga
Wednesday, January 04, 2017
A Peek Into The Markets: U.S. Stock Futures Rise; FOMC Minutes In Focus
Benzinga
Keep an Eye on These 7 Stocks for January 4, 2017
Benzinga
Tuesday, January 03, 2017
Acura Pharma Shares to Resume Trade at 4:45 p...
Benzinga
UPDATE: Acura Pharma Shares Were Halted at 4:...
Benzinga
Acura Pharma Announces Exploration of Strateg...
Benzinga
Wednesday, December 14, 2016
Acura Pharmaceutical Receives FDA Advice Identifying Longer Term Studies Needed For Submission of NDA For LTX-04
Benzinga
Friday, December 09, 2016
Acura Pharma Shares Recently Spike Higher in ...
Benzinga
Monday, November 14, 2016
Acura Pharmaceuticals Reports Q3 EPS $(0.75) ...
Benzinga
Tuesday, October 18, 2016
KemPharm Announces Aversion Licensed to Acura...
Benzinga
Monday, September 26, 2016
Acura Pharmaceuticals Spikes to High of $1.70...
Benzinga
Monday, August 08, 2016
Acura Pharma Reports Q2 EPS $(0.28), Inline, ...
Benzinga
Wednesday, June 08, 2016
Acura Pharma Reports LIMITX Technology Succes...
Benzinga
Wednesday, May 18, 2016
Worst Performing Industries For May 18, 2016
Benzinga
Monday, May 02, 2016
Acura Pharmaceuticals Reports Q1 EPS $(0.28) ...
Benzinga
Tuesday, April 26, 2016
Acura Pharmaceuticals Receives Second U.S. Patent for Novel Limitx Abuse Deterrent Technology
Benzinga
Wednesday, April 13, 2016
Acura Pharmaceutical's LimitxTechnology Successfully Shows Oral Abuse Deterrence
Benzinga
Tuesday, April 12, 2016
Acura Pharma's LTX-04 Receives FDA Fast Track
Benzinga
Friday, March 11, 2016
Benzinga's Top Initiations
Benzinga
Roth Capital Initiates Coverage on Acura Pharmaceuticals at Buy, Announces $6.00 PT
Benzinga
Monday, February 29, 2016
Acura Pharma Reports Q4 EPS $(0.08) Vs Est $(...
Benzinga
Monday, February 01, 2016
Acura Pharma Reports Clincal Testing On LTX-04 To Begin Q1 2016
Benzinga
Thursday, December 17, 2015
Acura Pharma Provides Updatye On Lumitx
Benzinga
Wednesday, December 16, 2015
Stocks Hitting 52-Week Lows
Benzinga
Wednesday, November 04, 2015
Acura Pharmaceuticals Reports Q3 EPS $(0.23) ...
Benzinga
Monday, October 12, 2015
Aura Announces $2.5M Milestone Payment From E...
Benzinga
Wednesday, September 09, 2015
Acura Pharma Announces Co. Egalet Have Commer...
Benzinga
Monday, August 24, 2015
Acura Pharmaceuticals Reports 1-For-5 Reverse...
Benzinga
Thursday, August 20, 2015
Top Performing Industries For August 20, 2015
Benzinga
Tuesday, August 04, 2015
Worst Performing Industries For August 4, 2015
Benzinga
Monday, August 03, 2015
Acura Pharma Reports Q2 Loss of $0.05/Share v...
Benzinga
Thursday, July 09, 2015
Shares of Acura Pharma Edge to Session Highs ...
Benzinga
Wednesday, July 01, 2015
Acura Pharma Announces Will Raise ~$7.6M from...
Benzinga
Monday, June 29, 2015
Top Performing Industries For June 29, 2015
Benzinga
Monday, May 04, 2015
Acura Pharma Reports Q1 EPS $0.03 vs. Est. $(...
Benzinga
Thursday, April 09, 2015
Acura Pharmaceuticals to Develop Abuse Deterrent Hydrocodone With Acetaminophen Tablets With Limitx Technology
Benzinga
Monday, March 23, 2015
Acura Pharmaceuticals Reports Successful Topl...
Benzinga
Monday, March 02, 2015
Acura Pharma Reports Q4 EPS $(0.06)
Benzinga
Friday, February 27, 2015
MLV & Co Upgrades Acura Pharmaceuticals To Buy
Benzinga
Show More
